Sales Enablement for Medical Device Teams

Build a review workflow: sales enablement creates the initial draft, regulatory affairs reviews all clinical claims and competitive statements, legal reviews positioning language, and marketing ensures brand compliance. Use only cleared indications, published clinical data, and factual competitive statements. Never include off-label claims or unsubstantiated superiority statements. Version-control every battle card with an approval date and reviewer name.

Focus on the quality and relevance of evidence, not just quantity. Highlight studies that are most recent, most relevant to the buyer's specific patient population, and published in the highest-impact journals. If your competitor has more studies but they're older or conducted in different populations, that's your angle. Also leverage real-world evidence, registry data, and post-market surveillance data alongside published studies.

Medical device battle cards need additional sections: FDA clearance status and cleared indications for both devices, key clinical studies with citations, compliance-approved competitive claims only, GPO contract positioning, and clinical outcome data. They should also clearly separate approved factual claims from general positioning language, and include the regulatory approval date and reviewer.

Lead with clinical value, not sales messaging. Share relevant published studies before requesting a meeting. Offer peer-to-peer connections with surgeons who use your device. Propose hands-on evaluations or cadaver labs rather than sales meetings. Use clinical education events as relationship-building opportunities. Your enablement should equip reps to be clinical consultants, not salespeople.

Three strategies: (1) Demonstrate total value beyond unit price — if your device reduces OR time, complication rates, or length of stay, quantify that savings and show it outweighs the contract price difference. (2) Leverage non-contract purchasing options by building a strong clinical preference case. (3) Work with your GPO contracting team to improve your tier positioning for future contract cycles, using clinical evidence and market share data.

Expect 2-3 weeks from initial draft to approved final version, accounting for regulatory and legal review cycles. Use our battle card generator to create the initial draft in 60 seconds, then spend 2-3 hours refining with clinical data and rep input. Submit for regulatory review (typically 5-10 business days), incorporate feedback, and distribute. The bottleneck is usually the review cycle, not the creation. Build relationships with your regulatory team to streamline approvals.